Zhejiang Int'l Group Co.,Ltd.

Equities

000411

CNE0000008D9

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
10.71 CNY +0.09% Intraday chart for Zhejiang Int'l Group Co.,Ltd. +4.39% -4.46%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Zhejiang Int'l Group Co.,Ltd. Announces Final Cash Dividend on A Shares for 2022, Payable on 08 June 2023 CI
Zhejiang Int'l Group Co.,Ltd. Approves Cash Dividend for 2022 CI
Zhejiang Int'l Group Co.,Ltd. Announces Profit Distribution Proposal for 2022 CI
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Zhejiang Int'l Group Co.,Ltd. agreed to acquire 51% stake in Hangzhou Baishan Medical Equipment Co., Ltd. from Shanghai Youjiang Enterprise Development Center (Limited Partnership), Shanghai Tuyu Enterprise Development Center (Limited Partnership), Yun Naiyi and Huang Haihua for CNY 100 million. CI
Zhejiang International to Buy Out Local Pharma Firm in 1.2 Billion Yuan Share Transfer Deal MT
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Zhejiang Int'l Group Co.,Ltd. announced that it has received CNY 399.999996 million in funding from Zhejiang CONBA Pharmaceutical Co.,Ltd. CI
Zhejiang International Secures Nod to Sell 400 Million Yuan of Shares MT
Zhejiang Int'l Group Co.,Ltd. completed the acquisition of remaining 50% stake in Zhejiang Int'l Medicine Co., Ltd. from Zhejiang Huachen Investment Development Co. Ltd. and Zhejiang International Business Group Co.,Ltd. CI
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Zhejiang Int'l Group Co.,Ltd. announces decision of Shareholder/Board on the transaction CI
Zhejiang Int'l Group Co.,Ltd. announced that it expects to receive CNY 400 million in funding CI
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Zhejiang Int'l Group Co.,Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2021, Payable on 17 June 2022 CI
Zhejiang Int'l Group Co.,Ltd. agreed to acquire remaining 50% stake in Zhejiang Int'l Medicine Co., Ltd. from Zhejiang Huachen Investment Development Co. Ltd. and Zhejiang International Business Group Co.,Ltd for CNY 2.3 billion. CI
Zhejiang Int'l Group Co.,Ltd. announced that it expects to receive CNY 449.99955 million in funding from Zhejiang CONBA Pharmaceutical Co.,Ltd. CI
Zhejiang Int'l Group Co.,Ltd. Approves Cash Dividend for the Year 2021 CI
Zhejiang International Halts Trading on M&A Plan MT
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
INT'LÂ Group Announces Final Profit Distribution Proposal for 2021 CI
Chart Zhejiang Int'l Group Co.,Ltd.
More charts
ZHEJIANG INT'L GROUP CO., LTD. is a China-based company principally engaged in the wholesale and retail of pharmaceuticals and medical equipment. The Company purchases products from pharmaceutical manufacturers or suppliers, then wholesales them to distributors, medical institutions and pharmacies, or sells them directly to consumers through retail terminals. The Company conducts its businesses in Mainland China.
More about the company
  1. Stock Market
  2. Equities
  3. 000411 Stock
  4. News Zhejiang Int'l Group Co.,Ltd.
  5. Zhejiang International to Buy Out Local Pharma Firm in 1.2 Billion Yuan Share Transfer Deal